MSP Recovery PE Ratio 2020-2024 | MSPR

Current and historical p/e ratio for MSP Recovery (MSPR) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. MSP Recovery PE ratio as of February 20, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

MSP Recovery PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-02-20 2.47 0.00
2024-09-30 0.15 $-144.25 0.00
2024-03-31 0.69 $-156.50 0.00
2023-12-31 2.27 $-125.00 0.00
2023-09-30 0.21 $-82.75 0.00
2023-06-30 0.33 $-81.00 0.00
2023-03-31 0.85 $-43.50 0.00
2022-12-31 1.60 $-99.75 0.00
2024-06-30 0.46 $-99.75 0.00
2022-09-30 1.20 $-62.50 0.00
2022-06-30 2.14 $-56.25 0.00
2022-03-31 10.26 0 0.00
2021-12-31 9.96 0 0.00
2021-09-30 9.91 0 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.018B $0.008B
MSP Recovery LLC. is a medicare, medicaid, commercial and secondary payer reimbursement recovery leader. It provides the healthcare industry with comprehensive compliance solutions. MSP Recovery LLC., formerly known as Lionheart Acquisition Corporation II, is based in CORAL GABLES, Fla.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $37.209B 54.83
Hims & Hers Health (HIMS) United States $15.018B 381.89
Tempus AI (TEM) United States $13.495B 0.00
Inspire Medical Systems (INSP) United States $5.303B 103.31
IRhythm Technologies (IRTC) United States $3.538B 0.00
Privia Health (PRVA) United States $3.060B 255.00
Enovis (ENOV) United States $2.533B 16.87
Clover Health Investments (CLOV) United States $2.280B 0.00
Azenta (AZTA) United States $2.075B 96.64
Schrodinger (SDGR) United States $1.895B 0.00
Omnicell (OMCL) United States $1.858B 40.53
Phreesia (PHR) United States $1.725B 0.00
10x Genomics (TXG) United States $1.465B 0.00
Butterfly Network (BFLY) United States $1.004B 0.00
Talkspace (TALK) United States $0.652B 0.00
Fulgent Genetics (FLGT) United States $0.531B 0.00
Standard BioTools (LAB) United States $0.517B 0.00
TruBridge (TBRG) United States $0.426B 124.04
Nyxoah SA (NYXH) Belgium $0.357B 0.00
Health Catalyst (HCAT) United States $0.338B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.319B 0.00
Pulmonx (LUNG) United States $0.262B 0.00
American Well (AMWL) United States $0.191B 0.00
EUDA Health Holdings (EUDA) Singapore $0.102B 0.00
MDxHealth SA (MDXH) Belgium $0.088B 0.00
P3 Health Partners (PIII) United States $0.077B 0.00
111 (YI) China $0.069B 0.00
CareCloud (CCLD) United States $0.063B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Outset Medical (OM) United States $0.050B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
SHL Telemedicine (SHLT) Israel $0.038B 0.00
Zhongchao (ZCMD) China $0.035B 0.00
Movano (MOVE) United States $0.034B 0.00
Bullfrog AI Holdings (BFRG) United States $0.028B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.013B 0.00
Precipio (PRPO) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.012B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.008B 0.00
Tivic Health Systems (TIVC) United States $0.005B 0.00
Syra Health (SYRA) United States $0.005B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00